Patents by Inventor Philippe DIOLEZ

Philippe DIOLEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
    Patent number: 11484529
    Abstract: The present invention relates to desmethylanethole trithione (AOX) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin,
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: November 1, 2022
    Assignees: OP2 Drugs, Centre Hospitalier Universitaire de Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux
    Inventors: Philippe Diolez, Frédéric Marin, Olivier Petitjean
  • Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
    Patent number: 11318113
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: May 3, 2022
    Assignees: OP2 DRUGS, CENTRE HOSPITALIER UNIVERSITAIRE DE BOURDEAUX, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE BORDEAUX
    Inventors: Philippe Diolez, Dominique Detaille, Frédéric Marin, Olivier Petitjean
  • DESMETHYLANETHOLE TRITHIONE DERIVATIVES FOR THE TREATMENT OF DISEASES LINKED TO MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PRODUCTION
    Publication number: 20210154175
    Abstract: The present invention relates to desmethylanethole trithione (AOX) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin,
    Type: Application
    Filed: March 7, 2018
    Publication date: May 27, 2021
    Applicants: OP2 Drugs, Centre Hospitalier Universitaire de Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux
    Inventors: Philippe Diolez, Frédéric Marin, Olivier Petitjean
  • COMPOUNDS FOR THE TREATMENT OF DISEASES LINKED TO MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PRODUCTION
    Publication number: 20200276156
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Application
    Filed: May 13, 2020
    Publication date: September 3, 2020
    Inventors: Philippe DIOLEZ, Dominique DETAILLE, Frédéric MARIN, Olivier PETITJEAN
  • Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
    Patent number: 10653668
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: May 19, 2020
    Assignees: OP2 DRUGS, CENTRE HOSPITALIER UNIVERSITAIRE DE BOURDEAUX, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE BORDEAUX
    Inventors: Philippe Diolez, Dominique Detaille, Frédéric Marin, Olivier Petitjean
  • COMPOUNDS FOR THE TREATMENT OF DISEASES LINKED TO MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PRODUCTION
    Publication number: 20190274997
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Application
    Filed: March 28, 2019
    Publication date: September 12, 2019
    Inventors: Philippe DIOLEZ, Dominique DETAILLE, Frédéric MARIN, Olivier PETITJEAN
  • Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
    Patent number: 10272066
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: April 30, 2019
    Inventors: Philippe Diolez, Dominique Detaille, Frédéric Marin, Olivier Petitjean
  • COMPOUNDS FOR THE TREATMENT OF DISEASES LINKED TO MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PRODUCTION
    Publication number: 20180256540
    Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
    Type: Application
    Filed: September 8, 2016
    Publication date: September 13, 2018
    Inventors: Philippe DIOLEZ, Dominique DETAILLE, Frédéric MARIN, Olivier PETITJEAN